The first vaccine against respiratory syncytial virus is 83% effective.
Academic rigor, journalistic flair
Articles on GSK
Displaying all articles
Big mergers are hugely complex, and not always popular with shareholders.
As part of an intiative to re-examine misrepresented or abandoned studies, we re-analysed an antidepressant trial. Here’s what we found.
The announcement that GlaxoSmithKline (GSK) aims to register a malaria vaccine came on the same day Peter Higgs and Francois Englert were awarded the Nobel prize in physics for predicting the existence…
China is in the midst of conducting a series of corruption investigations of pharmaceutical companies that have been operating in the country. It all started with the investigation of officials from pharmaceutical…
How would you feel if your local GP or specialist was pocketing money from a drug company to promote its products? If your gut tells you that this falls squarely into the category of Very Bad Ideas then…
Top contributors
-
Postdoctoral research fellow, University of Adelaide
-
Research Leader, Critical and Ethical Mental Health research group, Robinson Research Institute, University of Adelaide
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Professor of Bioethics, Macquarie University
-
Senior Lecturer in Communication, Deakin University
-
Professor of Molecular Parasitology and Medicine, St George's, University of London
-
Professor of Practice, Associate Dean, Warwick Business School, University of Warwick
-
Principal Lecturer, Microbiology and Biomedical Science Practice, Fellow of the Institute of Biomedical Science, University of Brighton
